Exposure to increased neighborhood violence has the power to change the glucocorticoid receptor (GR) for the stress hormone, ...

In the adult trial of 182 patients, those on crinecerfont had a 27.3% reduction in glucocorticoid dose compared with a 10.3% ...

(RTTNews) - Neurocrine Biosciences, Inc. (NBIX) Monday said CAHtalyst Pediatric and Adult Phase 3 Studies of Crinecerfont in congenital adrenal hyperplasia (CAH) met primary goals. Congenital adrenal ...

In a clinical guideline issued jointly by the European Society of Endocrinology and the Endocrine Society, recommendations ...

Current glucocorticoid replacement treatment is often given in supraphysiologic doses both to correct the deficiency and to ...

A retrospective analysis found glucocorticoid treatment to reduce comorbidities in adults with Duchenne muscular dystrophy ...

Lundbeck is to showcase innovative trial design at ENDO 2024 of the first in human trial of Lu AG13909 for congenital adrenal hyperplasia (CAH), a rare debilitating disease with excess morbidity and ...

Dupilumab significantly reduces exacerbations and improves lung function in COPD patients with elevated eosinophil counts, ...

Autoimmune polyendocrine syndrome type 1 (APS-1) is a life-threatening, autosomal recessive syndrome caused by autoimmune ...

Sparrow Pharmaceuticals, announced today that it will be attending the Endocrine Society (ENDO) 2024 Annual Conference. The ...

These studies have provided preliminary evidence for reduced PTSD incidence in glucocorticoid-treated patients. Researchers ...

Initial treatment of lupus nephritis with a high glucocorticoid dose improved outcomes but resulted in increased infections and early mortality.